Hungarian Scientists Identify Novel Biomarker of Mitochondrial Dysfunction in Long COVID
Nikhil Prasad Fact checked by:Thailand Medical News Team Nov 05, 2024 1 hour, 49 minutes ago
Medical News: In an exciting development, Hungarian researchers have uncovered a novel biomarker for mitochondrial dysfunction in patients suffering from Long COVID. This groundbreaking research reveals crucial insights into how SARS-CoV-2 impacts cellular structures and contributes to lingering symptoms that affect millions worldwide. Scientists believe this discovery could pave the way for better diagnostics and targeted treatments for those enduring post-COVID complications.
Hungarian Scientists Identify Novel Biomarker of Mitochondrial Dysfunction in Long COVID
The Link Between Mitochondria and Long COVID
For those unfamiliar, mitochondria serve as tiny energy factories within our cells, powering nearly every function our bodies perform. However, when these mitochondria experience dysfunction, it can lead to severe fatigue, cognitive issues, and other persistent symptoms commonly seen in Long COVID patients. In this
Medical News report, we delve into the study that revealed how mitochondria are altered in Long COVID cases, potentially pointing to new ways to identify and treat this condition.
Scientists from multiple institutions, including the Albert Szent-Györgyi Medical School at the University of Szeged in Hungary and the University of Pécs Medical School, Hungary, focused on post-COVID patients who continued to experience debilitating symptoms. By comparing these patients to healthy individuals, the researchers identified specific mitochondrial abnormalities that may serve as reliable indicators, or biomarkers, of Long COVID.
Study Methods: Uncovering the Changes in Mitochondrial Structure
The research team examined nasal and bronchial tissue samples from Long COVID patients. Utilizing advanced techniques like transmission electron microscopy, they identified structural changes in the mitochondria of those affected by Long COVID. These changes included mitochondrial swelling, irregular shapes, and a breakdown in the mitochondria’s cristae, the structures responsible for generating energy.
The study involved 32 post-COVID patients and 31 healthy controls, both of whom provided blood samples for mitochondrial DNA analysis. This analysis focused on circulating cell-free mitochondrial DNA (ccf-mtDNA), a fragment released into the bloodstream when mitochondria are under stress or damaged. The results revealed that Long COVID patients had significantly lower levels of ccf-mtDNA, suggesting impaired mitochondrial recycling and cellular stress.
Key Findings: New Biomarkers of Mitochondrial Stress
One of the most critical findings in the study was the identification of reduced ccf-mtDNA in Long COVID patients. This discovery has essential implications for diagnosis, as ccf-mtDNA levels could help identify those suffering from Long COVID more precisely. The scientists hypothesized that this mitochondrial biomarker might indicate that the body is struggling to recycle damaged mitochondria effectively. This impaired recycling process could be a central factor behind the persistent symptoms in
Long COVID.
The study also revealed elevated levels of superoxide dismutase 1 (SOD1) and autophagy-related 4B cysteine peptidase (ATG4B), proteins linked to oxidative stress and mitochondrial recycling. Higher levels of these proteins suggest that cells are undergoing intense oxidative stress, further contributing to mitochondrial dysfunction. These biomarkers not only confirm the role of mitochondria in Long COVID but also hint at potential treatment targets, as reducing oxidative stress might alleviate symptoms.
Implications for Diagnosing and Treating Long COVID
This novel biomarker could transform how doctors diagnose Long COVID. Traditional methods often rely on symptom-based diagnosis, which is highly subjective and varies from patient to patient. A blood test to measure ccf-mtDNA and SOD1 levels could give doctors a more precise tool to identify the condition and monitor its progression.
Moreover, these findings emphasize the importance of mitochondria in managing Long COVID symptoms, including fatigue, brain fog, and muscle weakness. Therapeutic interventions could focus on protecting mitochondria or enhancing their function. Antioxidants, lifestyle changes, and possibly even specific medications that target mitochondrial health may become part of future treatment plans for Long COVID.
Conclusion: A New Path Forward in Long COVID Research
The study provides a significant leap forward in understanding Long COVID, shedding light on how mitochondrial dysfunction contributes to its debilitating symptoms. These findings suggest that mitochondrial health could be a cornerstone in both diagnosing and treating Long COVID. As scientists continue to explore this avenue, they are optimistic that targeted interventions may one day reduce or even eliminate the persistent symptoms endured by millions globally.
The study findings were published in the peer-reviewed journal: GeroScience.
https://link.springer.com/article/10.1007/s11357-024-01398-4
For the latest COVID-19 News, keep logging on to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/latest-international-study-finds-that-sars-cov-2-virus-inhibits-mitochondrial-gene-transcription,-increasing-risk-of-organ-failure-and-death
https://www.thailandmedical.news/news/covid-19-and-our-cells-powerhouses-mitochondria
https://www.thailandmedical.news/news/covid-19-news-sars-cov-2-coronavirus-attacks-mitochondria,-the-power-house-of-cells-in-human-host-constant-fatigue-could-result-from-this
https://www.thailandmedical.news/news/mitochondrial-antioxidants-show-promise-in-reducing-covid-19-severity
https://www.thailandmedical.news/news/new-insights-into-mitochondrial-role-in-post-covid-recovery-and-long-covid-progression
https://www.thailandmedical.news/news/mitochondrial-dysfunction-biomarkers-and-curcumin-new-hope-for-severe-covid-19
https://www.thailandmedical.news/news/philadelphia-study-validates-that-sars-cov-2-causes-mitochondrial-metabolic-and-epigenomic-reprogramming
https://www.thailandmedical.news/news/murine-study-shows-that-sars-cov-2-nsp12-suppresses-mitochondrial-function-in-heart-tissues
https://www.thailandmedical.news/news/long-covid-news-study-finds-that-coenzyme-q10-supplementation-can-help-in-in-post-viral-fatigue-syndrome-caused-by-mitochondrial-dysfunction
https://www.thailandmedical.news/news/sars-cov-2-s-spike-protein-causes-host-s-cellular-shift-from-aerobic-to-anaerobic-energy-production-via-ldhb-enzyme-inhibition
https://www.thailandmedical.news/news/mitochondrial-dysfunction-and-metabolic-chaos-in-viral-infections
Share
Tweet
Share
